Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-018628

Director sold 36,285 shares at an average $31.36 ($1,137,819)

From the SEC's structured data for this filing

Trades in this filing

SCHAFFER DAVID · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-20 Sale : show line 1 in the form −11,565 $31.02 $358,771 925,935 D
2021-10-21 Sale : show line 2 in the form −22,820 $31.56 $720,156 903,115 D
2021-10-22 Sale : show line 3 in the form −1,900 $31.00 $58,893 901,215 D
Open-market sales · 36,285 sh · avg $31.36 · $1,137,819
Loading xslF345X03/doc1.xml…